Imaging

Mammography

Screening mammogram · Breast cancer screening

The standard screening tool for breast cancer in women. Cadence is the most-debated detail in screening medicine.

Strong relevance3 cited sourcesNo fastingPublic screening: free for eligible cohorts. Private: €60–180.nutrition

What it measures

Low-dose X-ray imaging of breast tissue, used to detect early breast cancer before clinical presentation. Modern 2D and 3D (digital breast tomosynthesis) variants improve detection in dense breasts.

Reference context

0 guideline sources

Birads scoring (0–6) is the standard report. Higher-density breasts have lower sensitivity; supplementary ultrasound or MRI may be discussed.

CAC 0
1–99
100–299
≥300
Lower riskHigher risk

Population context — consult guideline targets below

Mechanism

Why moving this marker matters

Early-stage breast cancer is generally more treatable. Population-level screening reduces breast-cancer mortality in women at average risk, with the largest absolute benefit in those over 50.

How to measure

The test, where to get it, when to repeat

Method

Brief X-ray procedure, 15–20 minutes. Two views per breast. Modest discomfort from compression. Radiation dose ~0.4 mSv per study.

Where

Hospital radiology, dedicated breast-screening clinics, mobile screening units. Most public systems offer organised screening for eligible age cohorts.

Typical cost

Public screening: free for eligible cohorts. Private: €60–180.

Fasting

Not required

When to test

  • USPSTF 2024

    40–74female

    Biennial screening for women 40–74 at average risk.

  • NICE / UK NHS BSP

    50–71female

    Triennial screening offered from 50–71.

  • EU Cancer Screening Recommendation 2022

    45–74female

    Organised screening 50–69 biennially; consider extending to 45–74 in some Member States.

Where to scan

Providers offering this imaging study

No direct-to-consumer provider currently in our directory for this scan — your GP, cardiologist, or radiologist can refer you.

Context

Reading the numbers

Birads scoring (0–6) is the standard report. Higher-density breasts have lower sensitivity; supplementary ultrasound or MRI may be discussed.

Caveats

Overdiagnosis is a real and contested feature of breast screening — some lesions found would never have caused harm. Discuss the absolute benefit vs harm balance with your physician.

Take to your physician

Worth discussing

  • Whether your family history or genetic background changes the recommended start age.
  • Whether breast density warrants supplementary screening.
  • How to weigh the overdiagnosis vs early-detection trade-off in your situation.

Sources

Cited literature

Edited by Carl Pöhl, MD · Healicus editorial

Last reviewed May 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading